Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0001104659-25-014160

Options or other derivatives

  • General Counsel acquired 102,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Kastenmayer James Paul General Counsel 2025-02-03 Grant or award · Stock Option (right to buy) +102,000 102,000 D
Loading xslF345X05/tm256714-1_4seq1.xml…